*These products are not available for purchase by the general public.
Hydrix Medical is committed to releasing breakthrough, technology-rich products, helping patients and medical professionals overcome cardiovascular health challenges.
Our team provides cutting-edge solutions that enhance the diagnosis, treatment, and management of CVD. We believe that by leveraging advanced cardiovascular technology, we can transform how CVD is managed, leading to improved patient care and outcomes. Our products are technologically advanced, user-friendly, and practical, tailored to the unique needs of patients and healthcare providers.
Breakthrough technology for enhanced cardiovascular care
AI-powered technology to enhance the diagnosis of structural heart disease.
ECHOSolv is a cloud-based platform is backed by the latest in medical technology, AI, and machine learning. This innovative decision-support tool is designed to highlight probability indicators for structural heart disease using echocardiographic measurement data from a standard cardiothoracic ultrasound.
Applying AI to transform the landscape of cardiac remote monitoring.
The first and only FDA-approved heart-attack warning system.
Cardiovascular Disease (CVD) is the world’s leading cause of death and places a significant burden on global healthcare systems. In 2019 it was the cause of one-third of all deaths globally and this number continues to rise.
Hydrix Medicals’ mission is to help tackle the global CVD crisis through the marketing and distribution of innovative CVD technologies and products that will transform lives.